Skip to content
DataLookout
Menu

NCT06190197

Prophylactic Antibiotics in Cystectomy With Diversion

StatusCompleted
PhaseEarly Phase 1
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 6 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 8 words Show 4 more changesShow less
    • Trial completed
    • Final enrollment: 53 participants (planned 120)
    • Primary completion date changed from estimate of Oct 15, 2027 to Oct 26, 2026
    • Site details revised
  2. Notable Primary and study completion dates: Oct 15, 2026 to Oct 15, 2027
    • Eligibility criteria expanded, about 3 words
    • Site contact updated
    v6
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 15, 2024 to May 13, 2024
    • Site details revised
    v4
  4. Notable Start date: Feb 28, 2024 to Apr 15, 2024
    • Primary and study completion dates: Aug 28, 2026 to Oct 15, 2026
    v3
  5. Notable Start date: Jan 2, 2024 to Feb 28, 2024
    • Primary and study completion dates: Jul 1, 2026 to Aug 28, 2026
    v2
  6. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

test for non-inferiority
Timeframe: 90 days
Difference in risk
Timeframe: 30 and 90 days

Arms and interventions

Control groupNo intervention

No prophylactic antibiotics post operatively. Participants will receive antibiotics only if needed post-operatively such as for infection

Treatment groupExperimental

Prophylactic antibiotics postoperatively.

Drugs: Prophylactic antibiotics postoperatively.

Sites

1 site in 1 country

  • University of MinnesotaMinneapolis, Minnesota, United States